G.T. Crisp et al. / Journal of Organometallic Chemistry 570 (1998) 219–224
223
3.6. 1-(1-Hexynyl)-4-methoxybenzene (1)
(0.09 ml, 8.21×10−4 mol), DBU (0.20 ml, 1.34×10−3
mol), ZnCl2 (not dried, 20 mg, 1.47×10−4 mol) and
NaI (22 mg, 1.47×10−4 mol). The resulting suspension
was then stirred at 60° for 3 h. The reaction mixture
was then added to CH2Cl2 (20 ml), washed with satu-
rated NH4Cl (20 ml) and the aqueous layer re-extracted
with another portion of CH2Cl2 (20 ml). The organic
layers were combined, washed once with water (40 ml),
dried and the solvent removed. The crude product was
purified by flash chromatography (eluant:-dichloro-
methane:hexane 2:1 (v/v), Rf 0.37) and then recrys-
tallised from hexane to give colourless needles (150 mg,
70%).
To a solution of 4-bromoanisole (0.30 ml, 2.39
mmol) in piperidine (3 ml) was added Pd(PPh3)4 (138
mg, 1.20×10−4 mol), 1-hexyne (0.30 ml, 2.64 mmol),
wet ZnCl2 (65 mg, 4.79×10−4 mol) and NaI (72 mg,
4.79×10−4 mol). The resulting suspension was then
stirred at 50°C for 16 h. The reaction mixture was then
added to CH2Cl2 (40 ml), washed with saturated NH4Cl
(40 ml) and the aqueous layer re-extracted with another
portion of CH2Cl2 (40 ml). The organic layers were
combined, dried and the solvent removed. The crude
product was passed through a squat column of silica
(eluant:- hexane:dichloromethane 5:1 (v/v), Rf 0.40) and
then further purified by flash chromatography, with the
same solvent system, to give the title compound as a
3.8. GLC experiments
1
colourless oil (412 mg, 92%). H-NMR: 0.94 (t, 2H, J 7
A standard protocol was used for all of the results
summarised in Table 2. To a solution of 4-bromoan-
isole (0.2 ml, 1.6 mmol) in solvent (3 ml) which had
been degassed by the freeze thaw method was added the
metal catalyst (0.054 mmol), 1-hexyne (0.22 ml, 1.92
mmol), ZnCl2 (not dried, 45 mg, 0.32 mmol), NaI (24
mg, 0.16 mol) and n-decane as an internal standard
(0.05 ml, 0.26 mmol). The resulting solution was then
stirred at 60°C and at regular intervals a sample was
withdrawn from the mixture, added to a vial containing
0.5 ml of 5% HCl solution and 0.5 ml of diethyl ether
and shaken. The ether layer was subjected to glc analy-
sis on a 30 m×0.53 mm DB1 Megabore column and
the % conversion of 4-bromoanisole to 1 was deter-
mined by the relative integrations of 1 versus the total
integrations for 1 and 4-bromoanisole relative to the
n-decane standard.
Hz), 1.50 (m, 4H), 2.39 (t, 2H, J 7 Hz), 3.79 (s, 3H),
6.80 (d, 2H, J 9 Hz), 7.30 (d, 2H, J 9 Hz); 13C-NMR:
13.5, 19.0, 21.9, 30.9, 55.0, 80.2 (CꢀC), 88.6 (CꢀC),
113.8, 132.2, 132.8, 159.0; m/z: 188 (M+, 84%), 173
(41), 159 (29), 145 (100), 115 (27); Ir (neat) (wmax, cm−1
2535 (CꢀC).
)
3.7. Dimethyl 5-(2-phenyl-1-ethynyl)isophthalate (2)
3.7.1. Method A
To a solution of dimethyl 5-bromoisophthalate (200
mg, 7.33×10−4 mol) in DMF (3 ml) was added
Pd(PPh3)4 (42 mg, 3.66×10−5 mol), phenylacetylene
(0.09 ml, 8.21×10−4 mol), triethylamine (0.20 ml,
2.76×10−3 mol), ZnCl2 (not dried, 20 mg, 1.47×10−4
mol), NaI (22 mg, 1.47×10−4 mol) and imidazole (10
mg, 1.47×10−4 mol). The resulting suspension was
then stirred at 60° for 16 h. The reaction mixture was
then added to CH2Cl2 (40 ml), washed with saturated
NH4Cl (40 ml) and the aqueous layer re-extracted with
another portion of CH2Cl2 (40 ml). The organic layers
were combined, dried and the solvent removed. The
crude product was then passed through a short column
of silica (eluant:-dichloromethane) to give a fawn solid.
Recrystallisation from hexane gave the title compound
as fine colourless needles (160 mg, 75%). Mp 115-116°;
Anal. Cald for C18H14O4: C, 73.46; H, 4.79. Found: C,
Acknowledgements
We would like to thank the Australian Research
Council for the award of an Australian Postgraduate
Award to P.D.T.
References
1
73.59; H, 4.57; H-NMR: 3.97 (s, 6H), 7.37 (m, 3H),
[1] K. Sonagashira, in: B.M. Trost, I. Fleming (Eds.), Comprehen-
sive Organic Synthesis, vol. 3, Pergamon Press, Oxford, 1991,
pp.521–549.
[2] M. Alami, F. Ferri, G. Linstrumelle, Tetrahedron Lett. 34 (1993)
6403.
[3] J.P. Genet, E. Blart, M. Savignac, Synlett (1992) 715.
[4] J.-F. Nguefack, V. Bolitt, D. Sinou, Tetrahedron Lett. 37 (1996)
5527.
7.54 (m, 2H), 8.36 (d, 2H, J 2 Hz), 8.63 (t, 1H, J 2 Hz);
13C-NMR: 52.4, 87.3 (CꢀC), 91.2 (CꢀC), 122.5, 124.4,
128.5, 128.9, 130.0, 130.9, 131.8, 136.5, 165.7 (CꢁO);
m/z 294 (M+, 89), 263 (44), 235 (14), 220 (21), 176
(61); Ir (nujol mull) (wmax, cm−1) 1722, 1736 (C=O),
2231 (CꢀC).
[5] (a) E.-I. Negishi, Acc. Chem. Res. 15 (1982) 340. (b) T.N.
Mitchell, Synthesis (1992) 803.
[6] (a) R.H. Grubbs, D. Kratz, Chem. Ber. 126 (1993) 149–157. (b)
A.P. Davey, S. Elliott, O. O’Connor, W. Blau, J. Chem. Soc.
Chem. Commun. (1995) 1433.
3.7.2. Method B
To a solution of dimethyl 5-bromoisophthalate (200
mg, 7.33×10−4 mol) in DMF (3 ml) was added
Pd(PPh3)4 (42 mg, 3.66×10−5 mol), phenylacetylene